An in vitro study on comparative adherence of oral Candida albicans and non–albicans Candida to human buccal epithelial cells and its antifungal susceptibility pattern

International Journal of Community Medicine and Public Health Asina PA et al. Int J Community Med Public Health. 2023 Jun;10(6):2125-2131 http://www.ijcmph.com pISSN 2394-6032 | eISSN 2394-6040

DOI: https://dx.doi.org/10.18203/2394-6040.ijcmph20231691

Original Research Article

An in vitro study on comparative adherence of oral Candida albicans

and non–albicans Candida to human buccal epithelial cells and its

antifungal susceptibility pattern

Asina P. A.1, Harish Kumar K. S.1*, Jacob Kuruvilla2, Divya Das1, Innu S.1,

Rani S. Jayamohan1, Roopa Mathews1

1Department of Medical Microbiology, School of Medical Education, Centre for Professional and Advanced Studies, Kottayam, Kerala, India 2Department of Public Health Dentistry, Mar Baselios Dental College, Ernakulam, Kerala, India Received: 18 March 2023 Accepted: 08 May 2023 *Correspondence: Dr. Harish Kumar K. S., E-mail: drharishkumarks@gmail.com Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

ABSTRACT Background: Candida spp. are intra-oral commensals in 40-60% of human subjects and the precise factors involved in the development of Candidiasis are still not clear. The adherence of Candida to epithelial cells is one of the main pathogenic characteristics of the genus. Studies have shown that there are variations in the adherence capabilities of different Candida spp., which may explain why some species colonize mucosal surfaces more frequently than others. The aim of this study was to estimate the adherence properties of Candida spp. to buccal epithelial cells and to determine the antifungal susceptibility. Methods: 87 isolates of Candida spp. from known non-diabetic patients with oral Candidiasis were collected from diagnostic microbiology laboratories in central Kerala. The method of Kimura and Pearsall et al was followed with minor modifications to test the adherence. Results: All the three species exhibited adherence with varying capacity. C. albicans was significantly more adherent to buccal epithelial cells than C. tropicalis and C. krusei. Resistance was not observed among the isolates against fluconazole, voriconazole and clotrimazole. Conclusions: In conclusion Candida spp. isolated from oral candidiasis patients exhibited a higher adherence capacity to normal human buccal epithelial cells considered an essential virulence property. As anticipated C. albicans displayed higher virulence activity than non-Candida albicans species. Keywords: Candida, Human buccal epithelial cell, Adherence, Antifungal susceptibility

INTRODUCTION

Yeast cells or blastospores are unicellular, eukaryotic organisms which multiply by a specific process of mitotic cell division known as budding.1 Yeast and yeast like organisms are the most common fungi isolated in clinical laboratories. Candida is one such medically important yeast-like fungi. Candida spp. are carried as part of commensal oral flora of 40% of healthy individuals,

normally without disease.2 There are 20 species of Candida among 700 species of microorganisms that are found in the oral cavity of humans.3,4 However, overgrowth of these organisms (usually as a result of lowered host defence) can cause clinical manifestations.5 Such pathogenicity can occur when the existing harmony between the host and the organism is altered, hence they are considered to be opportunistic pathogens.6 There are over 10 species of Candida that can cause infection in

International Journal of Community Medicine and Public Health | June 2023 | Vol 10 | Issue 6 Page 2125

Asina PA et al. Int J Community Med Public Health. 2023 Jun;10(6):2125-2131

humans, 80% of which is Candida albicans.7 Other medically important species include Candida glabrata (now renamed as Nakaseomyces glabrataa), Candida rugosa (now renamed as Diutina rugosa), Candida parapsilopsis, Candida tropicalis, Candida krusei (now renamed as Pichia kudriavzevii), Candida auris, Candida dublinensis, Candida kefyr (now renamed as Kluyveromyces marxianus) and Candida guilliermondii (now renamed as Meyerozyma guilliermondii).

Candida spp. can cause infection if there are predisposing conditions related to the host. The infective ability of this yeast-like fungi also depends on several virulence factors such as germ tube production, growth at 37°C, protease and phospholipase production and adherence to epithelial cells.8 The infection caused by these species are known as Candidiasis. It encompasses infections ranging from superficial infections, such as oral thrush and vaginitis, to systemic and potentially life-threatening diseases such as invasive candidiasis. In the pharmacological treatment of Candidiasis, the two classes of antifungals most commonly used are the polyenes and the azoles.

Adherence of Candida spp. to host cells constitute one of the first stages in the development of Candidiasis and is therefore an important factor during the colonization and invasion of tissues.9-12. Most of the results demonstrate that adhesion seems related to cell surface hydrophobicity.13,14 Candida possesses a set of proteins (adhesins) which mediate their adherence to other microorganisms, abiotic surfaces and to host cells.15 The aim of this study was to estimate the adherence properties of Candida spp. to buccal epithelial cells.

METHODS

The present cross-sectional study was conducted at School of Medical Education (SME), Kottayam, Kerala between January 2022 and December 2022. 87 isolates of Candida spp. from known non-diabetic patients with oral Candidiasis were collected from diagnostic microbiology laboratories in central Kerala. Candida albicans MTCC 227, procured from Institute of Microbial Technology (IMTECH), Chandigarh, India, was used as standard control for adherence assay and antifungal susceptibility testing. The isolates were reconfirmed by subculturing on to chromogenic media - HiCromeTM, followed by Gram staining and colonies were confirmed to be Gram positive yeast like budding cells. Further identification was done by tests like germ tube and chlamydospore production. All reagents, culture media and antifungal disc were procured from HiMedia Laboratories, Mumbai, India.

Test for adherence of Candida spp. to BEC

The method of Kimura and Pearsall et al was followed with minor modifications.16

Collection and washing of BEC

Buccal epithelial cells were collected from healthy individuals (in age range of 20-30 years) with no known coexisting disease or not in receipt of any medication that would affect the results of the study. Individuals with any known coexisting disease and those who have had any antimicrobial in the past 3 months were excluded. BECs, were collected from healthy male and female volunteers by scraping the buccal mucosa with the cotton-tipped sterile swab. Swabs were immersed in sterile PBS (pH 7.2), and vortexed. The cells were suspended in PBS, and washed 3 times in the buffer.

Harvesting and washing of Candida spp.

An overnight culture of Candida spp. in Sabouraud dextrose agar was washed 3 times in Phosphate buffered saline by centrifugation at 3000 rpm for 30 minutes.

Adherence assay

1 ml of washed Candida suspension was incubated with 1 ml of BEC suspension and incubated in a water-bath at 37°C for the hour. After this the BEC fungal suspension mixture was added to 5 ml PBS and centrifuged at 3000 rpm for 2 minutes. Supernatant containing the free Candida was discarded, the recovered BEC were re- suspended in 5 ml PBS and the process was repeated. Epithelial cells were suspended in 15 ml PBS and filtered allowing passage of any residual free fungi while retaining epithelial cells on the surface. After filtering, a glass microscopic slide was pressed gently against the filter, lifting off the retained epithelial cells. This cell preparation was air dried, alcohol fixed and Gram stained. The number of Candida adherent to each of the first 25 epithelial cells was counted. Only fungi that were in contact with the cell surface were counted and epithelial cells that overlapped other cells were excluded from the evaluation. The mean number of fungi per cell was calculated for each preparation.

Antifungal susceptibility testing

Antifungal disc diffusion susceptibility testing was done as prescribed by CLSI M44-A2.17 Briefly, Mueller- Hinton agar supplemented with 2% glucose and 0.5μg/ml methylene blue was used for the sensitivity testing. Antifungals used were fluconazole, voriconazole and clotrimazole. Interpretive criteria for fluconazole and voriconazole was as prescribed by CLSI M44-A217 and for clotrimazole as per manufacturers’ instructions.

This study was approved by the institutional ethical committee (IEC) at the School of Medical Education.

International Journal of Community Medicine and Public Health | June 2023 | Vol 10 | Issue 6 Page 2126

Source figureSource scientific regionSource scientific regionSource scientific regionSource table

Asina PA et al. Int J Community Med Public Health. 2023 Jun;10(6):2125-2131

Statistical analysis

The data was analysed using Microsoft excel 2019 and statistical package for the social sciences (SPSS) 16. Data were expressed as means ± standard deviation (SD).

RESULTS

A total of 87 Candida spp. was isolated from 65 males (74.7%) and 22 females (25.3%), which belonged to three species viz Candida albicans (n= 46), Candida tropicalis (n=26) and Candida krusei (n=15). C. albicans produced light green color, C. tropicalis blue color and C. krusei purple color as shown in Figure 1.

Figure 1: candida spp. on hicrometm agar. A- candida

albicans, B- candida tropicalis, C- candida krusei.

Figure 2: A- human BEC with adherent bacteria prior

to washing. B - washed BEC. C - candida spp.

Adhering to BEC post adherence assay.

Figure 3: Comparative adherence of candida spp. To

BEC.

All the three species exhibited adherence with varying capacity. Adherence of Candida spp. to buccal epithelial cell is shown in Figure 2. C. albicans exhibited an average adherence of 12.75 (SD=9.88), C. tropicalis 4.78 (SD=3.29) and C. krusei 7.71 (SD=6.28). The control strain, C. albicans MTCC 227 exhibited an average adherence of 2.2 (SD= 0.82). The comparative adherence to buccal epithelial cells is shown in Figure 3.

Figure 4: Frequency of adherence of Candida spp. to

BEC.

Table 1: Comparative adherence of Candida spp. to C. albicans MTCC 227 using t-test.

International Journal of Community Medicine and Public Health | June 2023 | Vol 10 | Issue 6 Page 2127

Source tableSource scientific region

Asina PA et al. Int J Community Med Public Health. 2023 Jun;10(6):2125-2131

Table 2: Comparative adherence between Candida spp. using t-test.

Figure 5: Antifungal susceptibility of Candida spp.

Sixteen C. albicans, sixteen C. tropicalis and seven C. krusei adhered in the range of 0 to 5 BEC. Seven C. albicans, seven C. tropicalis and three C. krusei adhered in the range of 6 to 10. Six C. albicans, three C. tropicalis and four C. krusei adhered in the range of 11 to 15. Five C. albicans adhered in the range of 16 to 20. Six C. albicans and one C. krusei adhered in the range of 21 to 25. Five C. albicans adhered in the range of 26 to 30. One C. albicans adhered in the range of 36 to 40. The frequency of adherence of Candida spp to BEC is shown in Figure 4.

The adherence of clinical isolates of C. albicans, C. tropicalis and C. krusei was compared with Candida albicans MTCC 227 (test value = 2.2) using t-test. C. albicans(p=0.00) and C. tropicalis(p=0.00) adherence was statistically significant when compared to the

standard strain C. albicans MTCC 227 while C. krusei adherence was insignificant, p=0.004 with a 95% confidence interval of difference as shown in the Table 1.

Adherence of clinical isolates of Candida spp. were compared using tukey’s HSD test.C. albicans showed a statistically significant level of adherence when compared to C. tropicalis (p=0.00) but was insignificant when compared to C. krusei (p=0.00). when adherence of C. tropicalis was compared to C. albicans, it showed a statistical significance, p=0.00 but was insignificant when compared to C. krusei. When the adherence of C. krusei was compared against C. albicans (p=0.08) and C. tropicalis (p=0.49) it was found insignificant (Table 2).

Antifungal susceptibility of Candida spp. is summarized in Figure 5. The rates of susceptibility to fluconazole

International Journal of Community Medicine and Public Health | June 2023 | Vol 10 | Issue 6 Page 2128

Asina PA et al. Int J Community Med Public Health. 2023 Jun;10(6):2125-2131

were 100% for C. albicans and C. tropicalis. C. krusei are intrinsically resistant to fluconazole. The rates of susceptibility to voriconazole were 100% for C. albicans, C. tropicalis and C. krusei. The antifungal susceptibility pattern of C. albicans against clotrimazole was, 95.65% sensitive and 4.35% intermediate. In case of C. tropicalis clotrimazole was sensitive to 80.77%, intermediate to 11.54% and resistant to 7.69%. C. krusei exhibited 93.33% and 6.67% susceptibility and intermediate susceptibility respectively.

DISCUSSION

Candida spp. are intra-oral commensals in 40-60% of human subjects and the precise factors involved in the development of Candidiasis are still not clear.18 The adherence of Candida to epithelial cells is one of the main pathogenic characteristics of the genus. Studies have shown that there are variations in the adherence capabilities of different Candida spp., which may explain why some species colonize mucosal surfaces more frequently than others.19-21 During both mucosal colonization and induction of disease Candida spp. interact with epithelial cells. Because the outcomes of these interactions are important in determining whether disease develops, they are subject of intense investigation by multiple laboratories around the world.22 In this study we evaluated the adherence capabilities of clinical isolates of Candida spp. to normal human buccal epithelial cells as it is a widely used model to study the adherence of Candida spp. and other microorganisms.2

The male to female proportion of distribution was similar to the study of Duggal et al, in non-diabetic individuals.23 The species wise distribution of Candida spp. in our study was similar to that of Duggal et al, A. Kalkanci et al and L. Bulacio et al, i.e, C. albicans followed by non-Candida albicans spp.23-25 The species distribution in our study was C. albicans 52.9%, C. tropicalis 29.9% and C.krusei 17.2%.

Adherence is an important pathogenic factor and the relation between yeasts’ adherence capacity and their ability to colonize mucous surfaces is an initial necessary requirement in its colonization which may later lead to an infectious process. Many studies have been carried out on the adherence, mainly of C. albicans strains, but very few researchers have examined the adherence of C. albicans and other non-Candida albicans spp. with comparative adherence to standard strain of Candida albicans.26-30 In the present study all the oral Candida isolates (100%) showed adherence to buccal epithelial cells, which is in accordance with the study of Arati et al.31 Adherence of Candida species to BEC from cases of oral candidiasis was significant when compared with a standard strain Candida albicans MTCC 227.

In the present study, C. albicans was significantly more adherent to BECs than C. tropicalis and C. krusei, which is in accordance with observations of Biasoli et al., Repentigny et al, Samaranayake et al, King et al, and

Critchley et al.33-36 The number of yeasts attached to buccal epithelial cells was in the range 0 to 36. This is in correlation with study of Sandin et al.37 We compared the adherence of clinical isolates of Candida spp. to C. albicans MTCC 227 and found a statistically significant adherence in C. albicans and C. tropicalis but not C. krusei. We further compared the adherence properties between species in which Candida albicans showed a statistically significant adherence over C. tropicalis but the adherence was not significant when compared to C. krusei. The variability in adherence of Candida spp. to BEC may be due to different population of cell receptors, environmental and host causes such as dietary and nutritional factors, or hormonal levels.

The most common antifungals used in treatment of candidiasis are azoles, polyenes and echinocandins. In the present study the Candida isolates showed high levels of sensitivity to the tested agents viz fluconazole, voriconazole and clotrimazole (Figure 4) which is in accordance with the study of Kuriyama et al.38 Antifungal susceptibility testing revealed 100% sensitivity to fluconazole by C. albicans and C. tropicalis. All the three Candida spp. showed 100% sensitivity to voriconazole and sensitivity to clotrimazole was 95.67%, 80.77% and 93.33% for C. albicans, C. tropicalis and C. krusei respectively.

Our study has some limitations as the isolates were collected only from a few centres. Our current knowledge of these adhesion events has relied largely on data obtained from in vitro experiments and primarily pertains to yeast interactions with epithelial cells as this ignores the possible role of many important hyphal adhesins. For a broader understanding of virulence factor of Candida spp., other virulence factors like enzymes, phenotypic switching, biofilm formation etc need to be studied.

CONCLUSION

In conclusion Candida spp. isolated from oral candidiasis patients exhibited a higher adherence capacity to normal human buccal epithelial cells considered an essential virulence property. As anticipated C. albicans displayed higher virulence activity than non-Candida albicans species. As the study revealed significant intra-species variation in Candida adhesion it is important to evaluate a larger number of isolates in order to elicit differences in relative adhesion among Candida species. Resistance to antifungal agents was not observed among the isolates tested.

ACKNOWLEDGEMENTS

Authors would like to thank Mrs. Rajumol B. Zacharia for her technical assistance.

Funding: No funding sources Conflict of interest: None declared Ethical approval: The study was approved by the Institutional Ethics Committee

International Journal of Community Medicine and Public Health | June 2023 | Vol 10 | Issue 6 Page 2129

Asina PA et al. Int J Community Med Public Health. 2023 Jun;10(6):2125-2131

REFERENCES

1. Webb BC, Thomas CJ, Willcox MD, Harty DW, Knox KW. Candida-associated denture stomatitis. Aetiology and management: a review. Part 1. Factors influencing distribution of Candida species in the oral cavity. Aust Dent J. 1998;43(1):45-50. 2. Sweet SP, Cookson S, Challacombe SJ. Candida albicans isolates from HIV-infected and AIDS patients exhibit enhanced adherence to epithelial cells. J Med Microbiol. 1995;43(6):452-7. 3. Tuominen H, Rautava J: Oral Microbiota and Cancer Development. Pathobiology 2021;88:116- 26. 4. Mizugai H, Isogai E, Hirose K, Chiba I. Effect of denture wearing on occurrence of Candida species in the oral cavity. Journal Of Applied Research In Clinical And Experimental Therapeutics. 2007;7(3):250. 5. Hsueh PR, Teng LJ, Yang PC, Ho SW, Luh KT. Emergence of nosocomial candidemia at a teaching hospital in Taiwan from 1981 to 2000: increased susceptibility of Candida species to fluconazole. Microb Drug Resist. 2002;8(4):311-9. 6. Enfert C, Hube B. Candida: Comparative and Functional Genomics. Caister Academic Press 2007. 7. James WD, Berger TG et al. Andrews' Diseases of the Skin: clinical Dermatology. Saunders Elsevier. 2006:308-311. 8. Koga-Ito CY, Lyon JP, Vidotto V, de Resende MA. Virulence factors and antifungal susceptibility of Candida albicans isolates from oral candidosis patients and control individuals. Mycopathologia. 2006;161(4):219-23. 9. Ghannoum MA. Candida albicans antifungal- resistant strains: studies on adherence and other pathogenicity related characteristics. Mycoses. 1992;35(5-6):131-9. 10. Miyakawa Y, Kuribayashi T, Kagaya K, Suzuki M, Nakase T, Fukazawa Y. Role of specific determinants in mannan of Candida albicans serotype A in adherence to human buccal epithelial cells. Infect Immun. 1992;60(6):2493-9 11. Ghannoum MA, Abu-Elteen KH. Pathogenicity determinants of Candida. Mycoses. 1990;33(6):265- 82. 12. McCourtie J, Douglas LJ. Relationship between cell surface composition, adherence, and virulence of Candida albicans. Infect Immun. 1984;45(1):6-12. 13. Ener B, Douglas LJ. Correlation between cell- surface hydrophobicity of Candida albicans and adhesion to buccal epithelial cells. FEMS Microbiol Lett. 1992;78(1):37-42. 14. Samaranayake YH, Wu PC, Samaranayake LP, So M. Relationship between the cell surface hydrophobicity and adherence of Candida krusei and Candida albicans to epithelial and denture acrylic surfaces. APMIS. 1995;103(10):707-13. 15. Ryley JF, Ryley NG. Candida albicans--do mycelia matter? J Med Vet Mycol. 1990;28(3):225-39.

16. Kimura LH, Pearsall NN. Adherence of Candida albicans to human buccal epithelial cells. Infect Immun. 1978;21(1):64-8. 17. M44 - Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts, 3rd Edition. Clinical and Laboratory Standards Institute. 18. Nair RG, Samaranayake LP. The effect of oral commensal bacteria on candidal adhesion to human buccal epithelial cells in vitro. J Med Microbiol. 1996;45(3):179-85. 19. Lima-Neto RG, Beltrão EI, Oliveira PC, Neves RP. Adherence of Candida albicans and Candida parapsilosis to epithelial cells correlates with fungal cell surface carbohydrates. Mycoses. 2011;54(1):23- 9. 20. Jabra-Rizk MA, Falkler WA Jr, Merz WG, Baqui AA, Kelley JI, Meiller TF. Cell surface hydrophobicity-associated adherence of Candida dubliniensis to human buccal epithelial cells. Rev Iberoam Micol. 2001;18(1):17-22. 21. de Repentigny L, Aumont F, Bernard K, Belhumeur P. Characterization of binding of Candida albicans to small intestinal mucin and its role in adherence to mucosal epithelial cells. Infect Immun. 2000;68(6):3172-9. 22. Zhu W, Filler SG. Interactions of Candida albicans with epithelial cells. Cell Microbiol. 2010;12(3):273-82. 23. Duggal R, Goswami R, Xess I, Duggal I, Talwar A, Mathur VP. Prevalence of species-specific candidiasis and status of oral hygiene and dentition among diabetic patients: A hospital-based study. Indian J Dent Res. 2021;32(3):292-298. 24. A. Kalkanci, E. Berk, B. Aykan, K. Caglar, K. Hizel, D. Arman, S. Kustimur. Epidemiology and antifungal susceptibility of Candida species isolated from hospitalized patients,Journal de Mycologie Médicale. 2007;17(1):16-20. 25. Bulacio L, Paz M, Ramadán S, Ramos L, Pairoba C, Sortino M, Escovich L, López C. Oral infections caused by yeasts in patients with head and neck cancer undergoing radiotherapy. Identification of the yeasts and evaluation of their antifungal susceptibility. J Mycol Med. 2012;22(4):348-53. 26. Sobel JD, Myers PG, Kayl D, Levinson ME. Adherence of Candida albicans to human vaginal and epithelial cell. J Infect Dis. 1981;143:76-82. 27. Sandin RL, Rogers A, Beneke E, Ferna´ndez M. Influence of mucosal cell origin on the in vitro adherence of Candida albicans: are mucosal cells from different sources equivalent? Mycopathologia. 1987;98:111-9. 28. Tronchin G, Bouchara JP, Annaix V, Robert R, Senet JM. Fungal cell adhesion molecules in Candida albicans. Eur. J. Epidemiol. 1991;7:23-33. 29. Pendrak ML, Klotz SA. Adherence of Candida albicans to host cells. FEMS Microbiol Lett. 1995;129:103-14. 30. Ollert MW, So¨hnchen R, Korting HC, Ollert U, Bra¨utigam S, Bra¨utigam W. Mechanisms of

International Journal of Community Medicine and Public Health | June 2023 | Vol 10 | Issue 6 Page 2130

Asina PA et al. Int J Community Med Public Health. 2023 Jun;10(6):2125-2131

adherence of Candida albicans to cultured human epidermal keratinocytes. Infect. Immun. 1993;61:4560-8. 31. Mane S, Gaikwad S, Bembalkar S, Risbud A. Increased expression of virulence attributes in oral Candida albicans isolates from human immunodeficiency virus- positive individuals. Journal of Medical Microbiology. 2012;61:285-90. 32. Biasoli MS, Tosello ME, Magaró HM. Adherence of Candida strains isolated from the human gastrointestinal tract. Mycoses. 2002;45(11-12):465- 9. 33. de Repentigny L, Aumont F, Bernard K, Belhumeur P. Characterization of binding of Candida albicans to small intestinal mucin and its role in adherence to mucosal epithelial cells. Infect Immun. 2000;68(6):3172-9. 34. Samaranayake YH, Wu PC, Samaranayake LP, So M, Yuen KY. Adhesion and colonization of Candida krusei on host surface. J Med Microbiol. 1994;41:250-8.

35. King RD, Lee JC, Morris AL. Adherence of Candida albicans and other Candida species to mucosal epithelial cells. Infect. Inmun. 1980;27:667-74. 36. Critchley IA, Douglas LJ. Differential adhesion of pathogenic Candida species to epithelial and inert surfaces. FEMS Microbiol. Lett. 1985;28:199-203. 37. Sandin RL, Rogers AL, Fernandez MI, Beneke ES. Variations in affinity to Candida albicans in vitro among human buccal epithelial cells. J Med Microbiol. 1987;24(2):151-5. 38. Kuriyama T, Williams DW, Bagg J, Coulter WA, Ready D, Lewis MA. In vitro susceptibility of oral Candida to seven antifungal agents. Oral Microbiol Immunol. 2005;20(6):349-53.

Cite this article as: Asina PA, Harish KKS, Kuruvilla J, Das D, Innu S, Jayamohan RS, et al. An in vitro study on comparative adherence of oral Candida albicans and non–albicans Candida to human buccal epithelial cells and its antifungal susceptibility pattern. Int J Community Med Public Health 2023;10:2125-31.

International Journal of Community Medicine and Public Health | June 2023 | Vol 10 | Issue 6 Page 2131